The role of cyproheptadine as an epigenetic modifier in restoring innate immune response in urothelial carcinoma
碩士 === 國立中正大學 === 生命科學系生物醫學研究所 === 106 === Urothelial carcinoma (UC), a complex and heterogeneous disease caused by both genetic, epigenetic and environmental factor, is one of the most common cancer in the world and second most common malignancy of the urinary system with high rate of recurrence. T...
Main Authors: | YEH, CHIH-CHIEH, 葉智傑 |
---|---|
Other Authors: | CHAN, MICHAEl WING-YAN |
Format: | Others |
Language: | en_US |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/4x6rqz |
Similar Items
-
Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
by: Yeong-Chin Jou, et al.
Published: (2021-04-01) -
Investigation of The Antitumor Mechanism of Cyproheptadine and The Role and Function of ANGPTL4 in Bladder Urothelial Carcinoma
by: Hsiao-Yen Hsieh, et al.
Published: (2016) -
Epigenetic Expression in Urothelial Cell Carcinoma
by: Ming-Fong Lin, et al. -
Epigenetic regulation of innate immune responses to infection
by: Pacis, Alain
Published: (2018) -
Ultrasensitive immunochromatographic strip for detection of cyproheptadine
by: Mengyuan Guo, et al.
Published: (2018-01-01)